Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.690
-0.080 (-1.68%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bicycle Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 327 | 491 | 967 | 767 | 879 | 1,790 | |
| Market Cap Growth | -29.49% | -49.19% | 26.03% | -12.72% | -50.89% | 367.95% | |
| Enterprise Value | -284 | -151 | 87 | 241 | 561 | 1,563 | |
| Last Close Price | 4.69 | 7.08 | 14.00 | 18.08 | 29.60 | 60.87 | |
| PS Ratio | 4.50 | 6.77 | 27.40 | 28.43 | 60.76 | 152.99 | |
| PB Ratio | 0.53 | 0.81 | 1.22 | 2.07 | 3.25 | 5.17 | |
| P/TBV Ratio | 0.54 | 0.81 | 1.22 | 2.07 | 3.25 | 5.17 | |
| EV/Sales Ratio | - | - | 2.46 | 8.92 | 38.82 | 133.63 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.01 | 0.12 | 0.16 | 0.13 | |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -1.10 | -1.30 | -1.09 | -1.14 | |
| Net Debt / EBITDA Ratio | 2.59 | 2.59 | 4.32 | 2.63 | 2.61 | 6.14 | |
| Net Debt / FCF Ratio | 2.42 | 2.42 | 5.24 | 7.58 | 2.81 | 23.44 | |
| Asset Turnover | 0.09 | 0.09 | 0.05 | 0.05 | 0.03 | 0.04 | |
| Quick Ratio | 11.65 | 11.65 | 13.61 | 7.92 | 6.76 | 12.43 | |
| Current Ratio | 11.98 | 11.98 | 13.81 | 8.08 | 6.93 | 12.65 | |
| Return on Equity (ROE) | -31.21% | -31.21% | -29.04% | -56.31% | -36.54% | -30.25% | |
| Return on Assets (ROA) | -18.13% | -18.13% | -16.81% | -23.60% | -16.38% | -12.80% | |
| Return on Capital Employed (ROCE) | -36.80% | -36.80% | -23.50% | -36.10% | -32.70% | -14.80% | |
| Earnings Yield | -66.98% | -44.58% | -17.49% | -23.55% | -12.83% | -3.73% | |
| FCF Yield | -77.09% | -51.32% | -17.17% | -8.29% | -11.96% | -0.94% | |
| Buyback Yield / Dilution | -19.02% | -19.02% | -63.54% | -20.00% | -18.35% | -30.90% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.